Table 1.
Baseline characteristics of included and excluded patients
Covariate | Missing IL-6 Level (n = 267) | With IL-6 Level (n = 552) | p |
---|---|---|---|
Age, year, mean [SD] | 66 [13] | 64 [13] | 0.05 |
Female, No. (%) | 106 (40) | 202 (37) | 0.39 |
Hypertension, No. (%) | 219 (93) | 467 (93) | 0.91 |
Hyperlipidemia, No. (%) | 72 (31) | 153 (31) | 0.89 |
Diabetes, No. (%) | 31 (13) | 60 (12) | 0.74 |
Atrial Fibrillation, No. (%) | 10 (4) | 19 (4) | 0.87 |
Coronary Artery Disease, No. (%) | 14 (6) | 28 (6) | 0.91 |
COPD, No. (%) | 4 (2) | 16 (3) | 0.44 |
ICH Location, No. (%) | 0.92 | ||
Non-lobar | 202 (81) | 433 (81) | |
Lobar | 35 (14) | 78 (15) | |
ICH Volume, mL, mean [SD] | 22 [25] | 23 [26] | 0.65 |
PHE Volume, mL, mean [SD] | 16 [18] | 18 [22] | 0.18 |
Presence of IVH, n (%) | 97 (36) | 205 (37) | 0.86 |
Treatment Group, No. (%) | 0.74 | ||
20 ug | 90 (34) | 172 (31) | |
80 ug | 81 (30) | 183 (33) | |
Placebo | 96 (36) | 197 (36) | |
Poor Outcome (mRS 4–6), No. (%) | 128 (48) | 262 (48) | 0.91 |
Abbreviations: SD = standard deviation, COPD = chronic obstructive pulmonary disease, ICH = intracerebral hemorrhage, PHE = perihematomal edema, IVH = intraventricular hemorrhage, mRS = modified Rankin Scale